Objectives: The prevalance of ED , underlying causes and comorbidities , why diagnosis of ED is important , ED could be the first sign of cardiovascular diseases , major risk factors , diagnostic tools and evaluation , recent management guidelines for ED , future and experimental treatments and rule of botox in ED
Introduction: Erectile dysfunction a major Male sexual Disorder , prevalence in some studies 52% of male above 40 years old , causes underlying could be psychogenic or organic mainly mixed , may be signal of underlying diseases , or cardiovascular disease , EHS used for diagnosis , recent and future management guidelines are available with significant result including intra corporal injection of botox
Materials / method: review of update researches in causes , recent management , future management , theories for erectile dysfunction management including Botox , P shot , Stem cells .
48 candidas to évalue the effective rule of Botox injection intra corporal injection , group A 24 control received IC 1 ml saline , group B 24 received IC single injection BTX-A 50 units
Results: significant results in the Sexual Encounter Profile , Global Assessment Questions ( GAQ) , and the erection hardness score (EHS) of the group B received IC BTX-A-50 units compared by the controlled group A received IC 1ml saline
Conclusion: The results suggest the possibility of intra- cavernosal BTX-A in treatment of patients with sever erectile dysfunction , and may lead to a reduction in the number of patients requiring penile implant surgery , results more significant if combined with immediate pumping ,
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
否
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。